Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/Eclampsia

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

December 27, 2017

Study Completion Date

January 22, 2018

Conditions
Preeclampsia/Eclampsia
Interventions
DRUG

Low dose magnesium sulphate

Participants in this arm will receive 4g of 20% intravenous (I.V.) MgSO4 (Magphate®) given over 10 minutes, followed by 3g of 50% intramuscular (I.M.) MgSO4 in each buttock statim. Then, maintenance doses will be given as 2.5g of 50% MgSO4 administered intramuscularly 4 hourly for 24 hours, for participants with severe preeclampsia and for 24 hours post delivery or post last seizure episode, whichever occurs last, for cohorts with eclampsia.

DRUG

Pritchard regimen

Participants in this arm will receive loading dose as 4g of 20% MgSO4 I.V. over 10 minutes, followed by 5g of 50% MgSO4 I.M. in each buttock. Maintenance doses will be given as 5g of 50% MgSO4 I.M. 4 hourly in alternate buttock until 24 hours for patients with eclampsia and for 24 hours after delivery or after last fit, whichever occurs later, for cohorts with eclampsia.

Trial Locations (1)

Unknown

Alex Ekwueme Federal University Teaching Hospital, Abakaliki

All Listed Sponsors
lead

Adebayo Joshua Adeniyi

OTHER

NCT04501289 - Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/Eclampsia | Biotech Hunter | Biotech Hunter